Home COVID-19 Topics

COVID-19

New and Noteworthy

Poll: Most Adults Do Not Expect to Get a COVID-19 Shot This Fall; Many Parents Confused About Recommendations for Children

As federal vaccine policy changes, this poll finds that most adults do not expect to get a COVID-19 vaccine this fall , and many parents are confused and uncertain about whether the vaccine is recommended for healthy children this year. About one in adults nationally say the changes to vaccine policy are making people safer, while more than a third say they are making people less safe.

Exploring misinformation about covid

COVID Vaccine Concerns

Narratives about an FDA memo claiming COVID-19 vaccines caused 10 pediatric deaths have evolved from focusing on the unverified claims to framing the announcement as evidence of a broader government “cover-up,” as some have characterized it as vindication for those previously “silenced” for raising vaccine safety concerns.

Changing COVID-19 Booster Policies

Misinformation about COVID-19 Vaccines

Vaccine Misinformation Spreads as Children Head Back to School

Debunked Study Undermines COVID-19 Vaccine Recommendations

Additional Resources

Global COVID-19 Tracker

This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths.

COVID-19 and Related State Data

Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospitalizations, vaccinations and mental illness.

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: COVID-19

Filter

List Grid

491 - 500 of 778 Results

  • Who Didn’t Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines

    Issue Brief

    As the U.S. prepares for nationwide distribution of vaccines to combat COVID-19, some are asking whether people who get the first of two doses will return to complete the series. This analysis draws on Medicare Part D prescription drug claims data for the herpes zoster vaccine Shingrix, which also requires two doses, to shed light on this potential challenge of the leading COVID-19 vaccine candidates.

  • This Week in Coronavirus: December 4 to December 10

    Policy Watch

    During the 47th week since the first coronavirus case appeared in the United States, the U.S. surpassed 15.6 million total cases as an independent Food and Drug Administration panel of outside advisers supported emergency use authorization for the Pfizer COVID-19 vaccine.

  • Estimates of the Initial Priority Population for COVID-19 Vaccination by State

    Issue Brief

    This analysis provides new national and state-level estimates of the number of health care workers and long-term care residents who are expected to be part of the group first in line to receive the COVID-19 vaccine to gain insight into how this initial priority population varies across states.

  • This Week in Coronavirus: November 26 to December 3

    Policy Watch

    During the 46th week since the first coronavirus case appeared in the United States, there was an increase of over 1.25 million confirmed cases between Nov. 26 and December 3. Approximately 12,900 confirmed deaths in the past week brought the total in the United States to 276,300.

  • Addressing Racial Equity in Vaccine Distribution

    Issue Brief

    This brief provides an overview of barriers to vaccination that disproportionately affect people of color and discusses how current national recommendations and state vaccine allocation plans address racial equity.